Research progress on neuropeptides in methamphetamine use disorder
CSTR:
Author:
Affiliation:

NHC Key Laboratory of Drug Addiction Medicine, School of Forensic Medicine, Kunming Medical University,Kunming 650500, China

Clc Number:

R-33

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Methamphetamine use disorder (MUD) is a refractory disorder with limited treatment options.There are evidences that neuropeptides might be a new target for the treatment of MUD. Studying the regulatory mechanism of neuropeptides in MUD may provide new options for treatment. However, there are many kinds of neuropeptides, the mechanism of action is complex, and clinical drug references are limited. This review focuses on orexin (OX), oxytocin (OT), vasopressin (VP), neurotensin (NT), neuropeptide S (NPS), neuropeptide Y (NPY), somatostatin (SST), pituitary adenylate cyclase-activating peptide (PACAP), vasoactive intestinal peptide (VIP), glucagon-like peptide-1 (GLP-1), and other neuropeptides as well. The regulatory role and mechanism of peptides in MUD are summarized, providing new directions for research and supporting the application of neuropeptides in the treatment of MUD.

    Reference
    Related
    Cited by
Get Citation
Related Videos

Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:May 06,2025
  • Revised:
  • Adopted:
  • Online: December 12,2025
  • Published:
Article QR Code